CA
ZBIO

Cliff Asness’s Zenas BioPharma ZBIO Stock Holding History

Cliff Asness’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$789K Sell
31,100
-19,871
-39% -$395K ﹤0.01% 3141
2026
Q1 		$996K Sell
50,971
-27,249
-35% -$612K ﹤0.01% 2776
2025
Q4 		$2.84M Buy
78,220
+53,636
+218% +$1.76M ﹤0.01% 1916
2025
Q3 		$546K Sell
24,584
-84
-0.3% -$1.37K ﹤0.01% 2775
2025
Q2 		$239K Buy
+24,668
New +$240K ﹤0.01% 2969

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Cliff Asness's ZBIO Position: Q2 2026 in Review

Cliff Asness reduced its Zenas BioPharma (ZBIO) stake by 39% in Q2 2026, selling an estimated $395K and leaving 31,100 shares worth $789K. The position accounts for ﹤0.01% of the portfolio, ranked #3141.

Cliff Asness first reported a position in ZBIO in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.84M in Q4 2025. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Cliff Asness held 31,100 shares of Zenas BioPharma worth $789K as of Q2 2026.
  • Cliff Asness sold 19,871 Zenas BioPharma shares in Q2 2026, an estimated $395K.
  • Zenas BioPharma made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3141 holding.
  • Cliff Asness first reported a position in Zenas BioPharma in Q2 2025 and has held it in 5 quarters since.
  • Cliff Asness's Zenas BioPharma position peaked at $2.84M in Q4 2025.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.